๐ฉบ SirPAD study update focuses on PAD patients
New results from the SirPAD randomized trial will be shown at VIVA 2026 in Las Vegas. This study involved 1,252 patients with symptomatic infrainguinal PAD receiving either MagicTouch angioplasty or an uncoated balloon. The new analysis focuses on 597 patients with femoropopliteal disease, aiming for symptom relief beyond just limb preservation. Prof. Dr. Stefano Barco will present these findings during the late-breaking clinical trial program at VIVA 2026. This data will provide insights into a clinically important population needing better vascular care. ๐ฉบ